Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexandra Power-Hays, MD
Children's Hospital Medical Center, Cincinnati
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Korle Bu Teaching Hospital
Accra, Ghana, Ghana
Catherine Segbefia, MBChB, FWACP, GGCPSRecruiting
- Bugando Medical Centre
Mwanza, Tanzania
Emmanuela Ambrose, MD, MMEDRecruiting
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Charles Quinn, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Mar 2025
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2028
- Last update posted
- 21 Jan 2026
- Registered enrollment
- 130
- Registry id
- NCT07356050
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.